Seventh KidneyIntelX implementation partnership for Renalytix focused on underserved populations with high disease burden
National program establishes early care management, technology innovation and large health system engagement as a strategic priority for supporting the 34 million U.S. individuals living with diabetes
Series A Financing Funds Multiple Programs to Phase 1 and IND stage
Definitive merger agreements provide the Company with all existing and future assets, future product iterations, and intellectual property rights of the platform, creating a fully integrated product line and streamlining commercialization
Publication in Journal of the American College of Cardiology (JACC): Cardiovascular Interventions Found TRIA Aortic Heart Valve Provided Sustained Improvement in Heart Valve Function to One-Year with Good Safety Profile
PolarityTE has submitted its complete response to the U.S. FDA clinical hold correspondence regarding its Investigational New Drug (IND) Application for SkinTE® with a proposed indication for chronic cutaneous ulcers.
Myriad Genetics Promotes Nicole Lambert to Chief Operating Officer
Teiko.bio Launches with $11.6 Million Series A Financing to Advance High-Dimension Immune Profiling for Clinical Trials and Diagnostics Development.
Rosivo closes seed-round paving the path for commercialization of patented cartilage implant technology
IONIQ Sciences, Inc. announced it has been awarded “Most Innovative Non-Invasive Lung Cancer Testing Solution” and “Best Medical Technology Company 2021” by Global 100.
Powerful combination of key patents comes as the Company looks ahead to topline results from a Phase 3 registration study in ALS in second half of 2022.
Clene presented data from the RESCUE-ALS Phase 2 study of CNM-Au8®, a catalytically active gold nanocrystal suspension, for the treatment of amyotrophic lateral sclerosis (ALS).